These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
752 related articles for article (PubMed ID: 16485345)
1. Epigenetic therapy of cancer: past, present and future. Yoo CB; Jones PA Nat Rev Drug Discov; 2006 Jan; 5(1):37-50. PubMed ID: 16485345 [TBL] [Abstract][Full Text] [Related]
2. Targeting components of epigenome by small molecules. You JS; Han JH Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764 [TBL] [Abstract][Full Text] [Related]
3. DNA demethylating agents and epigenetic therapy of cancer. Mani S; Herceg Z Adv Genet; 2010; 70():327-40. PubMed ID: 20920754 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
6. Molecular targets for epigenetic therapy of cancer. Humeniuk R; Mishra PJ; Bertino JR; Banerjee D Curr Pharm Biotechnol; 2009 Feb; 10(2):161-5. PubMed ID: 19199948 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic drugs take on cancer. Kaiser J Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620 [No Abstract] [Full Text] [Related]
8. Epigenetic therapy of cancer with histone deacetylase inhibitors. Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic agents in combined anticancer therapy. Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175 [TBL] [Abstract][Full Text] [Related]
10. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Mai A; Altucci L Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic cancer therapy: Proof of concept and remaining challenges. Mund C; Lyko F Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865 [TBL] [Abstract][Full Text] [Related]
14. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation. Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic therapies reach main street. Bates SE Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089 [No Abstract] [Full Text] [Related]
16. Promising strategies: Combination of epigenetic inhibitors for cancer therapy. Gronemeyer H Int J Cancer; 2020 Nov; 147(10):2656-2657. PubMed ID: 32599650 [No Abstract] [Full Text] [Related]
17. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors. Yang AS; Yang BJ Epigenomics; 2016 Jan; 8(1):9-12. PubMed ID: 26698294 [No Abstract] [Full Text] [Related]
18. Epigenetic therapy for solid tumors: from bench science to clinical trials. Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532 [TBL] [Abstract][Full Text] [Related]